HFS
LGND icon

Hantz Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Hantz Financial Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$13K Buy
113
+53
+88% +$6.1K ﹤0.01% 1429
2025
Q1 		$6K Sell
60
-7,767
-99% -$777K ﹤0.01% 1112
2024
Q4 		$839K Buy
+7,827
New +$839K 0.01% 451